BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 25617073)

  • 21. [Clinical study on fluoroquinolone prophylaxis in neutropenia patients with acute leukemia].
    Qin TJ; Mi YC; Feng SZ; Li DP; Wei JL; Yang DL; Han MZ; Wang JX; Bian SG
    Zhonghua Yi Xue Za Zhi; 2007 May; 87(20):1389-93. PubMed ID: 17785058
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Retrospective analysis of fluoroquinolone prophylaxis in patients undergoing allogeneic hematopoietic stem cell transplantation.
    Simondsen KA; Reed MP; Mably MS; Zhang Y; Longo WL
    J Oncol Pharm Pract; 2013 Dec; 19(4):291-7. PubMed ID: 23184539
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bacterial Infections in Children With Acute Myeloid Leukemia Receiving Ciprofloxacin Prophylaxis.
    Al Omar S; Anabtawi N; Al Qasem W; Rihani R
    J Pediatr Hematol Oncol; 2017 Apr; 39(3):e131-e135. PubMed ID: 28234737
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Evaluation of antibiotic prophylaxis in neutropenic patients with hematologic malignancies].
    Delarive P; Baumgartner JD; Glauser MP; Cometta A
    Schweiz Med Wochenschr; 2000 Dec; 130(48):1837-44. PubMed ID: 11132527
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ciprofloxacin reduces occurrence of fever in children with acute leukemia who develop neutropenia during chemotherapy.
    Laoprasopwattana K; Khwanna T; Suwankeeree P; Sujjanunt T; Tunyapanit W; Chelae S
    Pediatr Infect Dis J; 2013 Mar; 32(3):e94-8. PubMed ID: 23080291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Audit of fluoroquinolone prophylaxis against chemotherapy-induced febrile neutropenia in a hospital with highly prevalent fluoroquinolone resistance.
    Ng ES; Liew Y; Earnest A; Koh LP; Lim SW; Hsu LY
    Leuk Lymphoma; 2011 Jan; 52(1):131-3. PubMed ID: 20929324
    [No Abstract]   [Full Text] [Related]  

  • 27. Clinical and microbiologic outcomes of quinolone prophylaxis in children with acute myeloid leukemia.
    Felsenstein S; Orgel E; Rushing T; Fu C; Hoffman JA
    Pediatr Infect Dis J; 2015 Apr; 34(4):e78-84. PubMed ID: 25764103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bacteremia and fungemia in pediatric versus adult cancer patients after chemotherapy: comparison of etiology, risk factors and outcome.
    Krupova I; Kaiserova E; Foltinova A; Kovacicova G; Kiskova M; Krchnakova A; Kunova A; Trupl J; West D; Krcmery V
    J Chemother; 1998 Jun; 10(3):236-42. PubMed ID: 9669650
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pneumocystis jirovecii pneumonia in solid organ transplant recipients: a descriptive analysis for the Swiss Transplant Cohort.
    Neofytos D; Hirzel C; Boely E; Lecompte T; Khanna N; Mueller NJ; Boggian K; Cusini A; Manuel O; van Delden C;
    Transpl Infect Dis; 2018 Dec; 20(6):e12984. PubMed ID: 30155950
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Severe infections in children with acute leukemia undergoing intensive chemotherapy can successfully be prevented by ciprofloxacin, voriconazole, or micafungin prophylaxis.
    Yeh TC; Liu HC; Hou JY; Chen KH; Huang TH; Chang CY; Liang DC
    Cancer; 2014 Apr; 120(8):1255-62. PubMed ID: 24415457
    [TBL] [Abstract][Full Text] [Related]  

  • 31. No recurrence of Pneumocystis jirovecii Pneumonia after solid organ transplantation regardless of secondary prophylaxis.
    Kim T; Sung H; Lee YM; Hong HL; Kim SH; Choi SH; Woo JH; Kim YS; Lee SO
    Antimicrob Agents Chemother; 2012 Nov; 56(11):6041-3. PubMed ID: 22948875
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of antibacterial prophylaxis for patients with neutropenia. Australian Consensus Guidelines 2011 Steering Committee.
    Slavin MA; Lingaratnam S; Mileshkin L; Booth DL; Cain MJ; Ritchie DS; Wei A; Thursky KA;
    Intern Med J; 2011 Jan; 41(1b):102-9. PubMed ID: 21272174
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fluoroquinolone prophylaxis: a word of caution.
    Lingaratnam S; Thursky KA; Slavin MA
    Leuk Lymphoma; 2011 Jan; 52(1):5-6. PubMed ID: 21067448
    [No Abstract]   [Full Text] [Related]  

  • 34. Levofloxacin to prevent bacterial infection in patients with cancer and neutropenia.
    Bucaneve G; Micozzi A; Menichetti F; Martino P; Dionisi MS; Martinelli G; Allione B; D'Antonio D; Buelli M; Nosari AM; Cilloni D; Zuffa E; Cantaffa R; Specchia G; Amadori S; Fabbiano F; Deliliers GL; Lauria F; Foà R; Del Favero A;
    N Engl J Med; 2005 Sep; 353(10):977-87. PubMed ID: 16148283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective oral antimicrobial prophylaxis for the prevention of infection in acute leukaemia-ciprofloxacin versus co-trimoxazole plus colistin. The EORTC-Gnotobiotic Project Group.
    Donnelly JP; Maschmeyer G; Daenen S
    Eur J Cancer; 1992; 28A(4-5):873-8. PubMed ID: 1524913
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Levofloxacin for febrile neutropenia prophylaxis in acute myeloid leukemia patients associated with reduction in hospital admissions.
    Lee SSF; Fulford AE; Quinn MA; Seabrook J; Rajakumar I
    Support Care Cancer; 2018 May; 26(5):1499-1504. PubMed ID: 29170868
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Meta-analysis: antibiotic prophylaxis reduces mortality in neutropenic patients.
    Gafter-Gvili A; Fraser A; Paul M; Leibovici L
    Ann Intern Med; 2005 Jun; 142(12 Pt 1):979-95. PubMed ID: 15968013
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ciprofloxacin prophylaxis in patients with acute leukemia and granulocytopenia in an area with a high prevalence of ciprofloxacin-resistant Escherichia coli.
    Gomez L; Garau J; Estrada C; Marquez M; Dalmau D; Xercavins M; Martí JM; Estany C
    Cancer; 2003 Jan; 97(2):419-24. PubMed ID: 12518366
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and Safety of Dapsone Versus Trimethoprim/Sulfamethoxazol for Pneumocystis Jiroveci Prophylaxis in Children With Acute Lymphoblastic Leukemia With a Background of Ethnic Neutropenia.
    Nazir HF; Elshinawy M; AlRawas A; Khater D; Zadjaly S; Wali Y
    J Pediatr Hematol Oncol; 2017 Apr; 39(3):203-208. PubMed ID: 28234744
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Fluoroquinolone resistance of Escherichia coli at a cancer center: epidemiologic evolution and effects of discontinuing prophylactic fluoroquinolone use in neutropenic patients with leukemia.
    Kern WV; Klose K; Jellen-Ritter AS; Oethinger M; Bohnert J; Kern P; Reuter S; von Baum H; Marre R
    Eur J Clin Microbiol Infect Dis; 2005 Feb; 24(2):111-8. PubMed ID: 15714332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.